CoChat

Phenotypic Resistance to Antibiotics

Open access
Corona, Fernando, Martinez, Jose · 2013 · Antibiotics

The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.

Abstract

The development of antibiotic resistance is usually associated with genetic changes, either to the acquisition of resistance genes, or to mutations in elements relevant for the activity of the antibiotic. However, in some situations resistance can be achieved without any genetic alteration; this is called phenotypic resistance. Non-inherited resistance is associated to specific processes such as growth in biofilms, a stationary growth phase or persistence. These situations might occur during infection but they are not usually considered in classical susceptibility tests at the clinical microbiology laboratories. Recent work has also shown that the susceptibility to antibiotics is highly dependent on the bacterial metabolism and that global metabolic regulators can modulate this phenotype. This modulation includes situations in which bacteria can be more resistant or more susceptible to antibiotics. Understanding these processes will thus help in establishing novel therapeutic approaches based on the actual susceptibility shown by bacteria during infection, which might differ from that determined in the laboratory. In this review, we discuss different examples of phenotypic resistance and the mechanisms that regulate the crosstalk between bacterial metabolism and the susceptibility to antibiotics. Finally, information on strategies currently under development for diminishing the phenotypic resistance to antibiotics of bacterial pathogens is presented.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antibiotics2020237

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Some situations of transient changes of bacterial susceptibility to antibiotics are described. (A) Drug indifference occurs when the antibiotic is effective only in a specific bacterial physiological condition. This situation was first described for β-lactam antibiotics that do not kill non-dividing growing cells; (B) In a bacterial population, there is a subpopulation of cells called persistents that are not killed by antibiotics in conditions that kill the bulk of the population. Once growth resumes, these persistent bacteria become susceptible to antibiotics, indicating that the phenotype of resistance is transient, not being the consequence of a genetic change; (C) Bacteria usually grow forming biofilms when attached to surfaces and under these conditions they are more resistant to antibiotics. Gradients of nutrients and of oxygen cause different metabolic states in the bacteria depending on their depth inside the biofilm, which can affect their susceptibility to antibiotics. Moreover, compounds of the matrix can impair the diffusion of the antibiotic and eventually bind the drug thus reducing its free concentration. Quorum sensing, which can be triggered at dense regions of the biofilm, may also alter bacterial susceptibility to antibiotics. (D) Bacteria change their permeability to antibiotics in response to several environmental and internal factors such as temperature, the presence of specific inducers, reactive oxygen species (ROS) or specific metabolic situations. Changes can affect antibiotic susceptibility at several levels. First, reducing the binding of the antibiotic by modification of the lipopolysaccharide (LPS), or generating outer membrane vesicles that give rise to more surface and minimizes the effective amount of the antibiotic per cell. Second, modifying the number or type of bacterial porins, the aqueous channels used by the antibiotic to penetrate inside bacteria, might help keeping the antibiotics out of the cell. Third, expressing multiple efflux pumps that extrude the antibiotic once it has reached the cytoplasm decreases the toxic activity of the antibiotic.
Figure 1 Some situations of transient changes of bacterial susceptibility to antibiotics are described. (A) Drug indifference occurs when the antibiotic is effective only in a specific bacterial physiological condition. This situation was first described for β-lactam antibiotics that do not kill non-dividing growing cells; (B) In a bacterial population, there is a subpopulation of cells called persistents that are not killed by antibiotics in conditions that kill the bulk of the population. Once growth resumes, these persistent bacteria become susceptible to antibiotics, indicating that the phenotype of resistance is transient, not being the consequence of a genetic change; (C) Bacteria usually grow forming biofilms when attached to surfaces and under these conditions they are more resistant to antibiotics. Gradients of nutrients and of oxygen cause different metabolic states in the bacteria depending on their depth inside the biofilm, which can affect their susceptibility to antibiotics. Moreover, compounds of the matrix can impair the diffusion of the antibiotic and eventually bind the drug thus reducing its free concentration. Quorum sensing, which can be triggered at dense regions of the biofilm, may also alter bacterial susceptibility to antibiotics. (D) Bacteria change their permeability to antibiotics in response to several environmental and internal factors such as temperature, the presence of specific inducers, reactive oxygen species (ROS) or specific metabolic situations. Changes can affect antibiotic susceptibility at several levels. First, reducing the binding of the antibiotic by modification of the lipopolysaccharide (LPS), or generating outer membrane vesicles that give rise to more surface and minimizes the effective amount of the antibiotic per cell. Second, modifying the number or type of bacterial porins, the aqueous channels used by the antibiotic to penetrate inside bacteria, might help keeping the antibiotics out of the cell. Third, expressing multiple efflux pumps that extrude the antibiotic once it has reached the cytoplasm decreases the toxic activity of the antibiotic.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 211

Metadata

Authors
Corona, F., & Martinez, J.
Affiliations
  • Consejo Superior de Investigaciones Científicas (ES)
  • Centro Nacional de Biotecnología, CSIC, Darwin 3, 28049-Madrid, Spain
Venue
Antibiotics
Publisher
MDPI AG
Published
2013-04-18
Volume
2
Issue
2
Pages
237-255
ISSN
2079-6382 (ISSN-L)
OpenAlex
W2086293991
Cited by
205
References
143
Citations by year
2026: 12 · 2025: 21 · 2024: 24 · 2023: 30 · 2022: 27 · 2021: 20 · 2020: 17 · 2019: 17 · 2018: 12 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 1
FWCI
0.78
Type
journal article
Language
en
Open access
Locations
  • Antibiotics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • European Commission (241476, 282004)
  • Ministerio de Ciencia e Innovación (BIO2011-25255)
  • Instituto de Salud Carlos III
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords
phenotypic antibiotic resistance, biofilm, bacterial persistence, stationary phase, bacterial metabolism, antimicrobial susceptibility testing, pathogenic bacteria

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.